Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CSSi LifeSciences formalized a strategic partnership agreement with PRC Clinical, a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences is specialized in strategic, marketing, and regulatory consulting, FDA advisory services, and patient recruitment services.
Subscribe to our email newsletter
The core expertise of PRC Clinical is focused on Clinical Trial Management, Clinical Site Monitoring, and Clinical Payment Services. The CSSi LifeSciences and PRC Clinical partnership equips both firms with the ability to guide and support sponsors through the entire drug development lifecycle, from strategic, regulatory, clinical operations, and marketing standpoints.
CSSi LifeSciences has successfully supported the development of over 500 new drugs, biologics, medical devices and in-vitro diagnostics for sponsors in the United States, Europe, Asia, and the Middle East. PRC Clinical has supported phase I-IV clinical studies for pharmaceutical and medical device companies globally.
CSSi LifeSciences and PRC Clinical are respectively headquartered in Baltimore, MD and San Bruno, CA. The signature of this partnership agreement will strengthen both firms in their ability to seamlessly support sponsors across the United States and Globally.
"We are excited to establish our strategic partnership with PRC Clinical to leverage our skills, services and brain trust to help bring complementary and specialized clinical trial services to local and global clients," said Jim Sergi, President of CSSI LifeSciences.
The new partnership benefits pharmaceutical and medical device companies by simplifying the outsourcing process for full-service projects.
"The PRC Clinical team is excited to work in a formalized relationship with CSSi LifeSciences and to support local and global clinical trials across the drug development lifecycle," stated Curtis Head, CEO at PRC Clinical.
CSSi LifeSciences and PRC Clinical share a strong belief in providing personalized client and patient centric services, as well as a similar management style in providing uncompromising SOP driven standards.
In joining resources, clients will receive best in class services to provide insight driven analysis and more informed decision making to increase commercial success, while reducing the risk for late-stage failures and post-authorization action.